Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tailor-made antibody therapeutics.

Partha S Chowdhury1, Herren Wu

  • 1Department of Antibody Discovery and Protein Engineering, MedImmune, Inc., One MedImmune Way, Gaithersburg, MD 20878, USA. chowdhuryp@medimmune.com

Methods (San Diego, Calif.)
|April 26, 2005
PubMed
Summary

Engineered therapeutic antibodies are revolutionizing medicine. This review details how scientists are tailoring antibody molecules for enhanced drug efficacy in various biological applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodies.

Scientific reports·2026
Same author

Unveiling inverted D genes and D-D fusions in human antibody repertoires unlocks novel antibody diversity.

Communications biology·2025
Same author

Honing-in antigen-specific cells during antibody discovery: a user-friendly process to mine a deeper repertoire.

Communications biology·2022
Same author

A Hoechst Reporter Enables Visualization of Drug Engagement <i>In Vitro</i> and <i>In Vivo</i>: Toward Safe and Effective Nanodrug Delivery.

ACS nano·2022
Same author

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance.

Communications biology·2021
Same author

Correction: Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models.

PloS one·2021

Area of Science:

  • Pharmaceutical Science
  • Biotechnology
  • Drug Development

Background:

  • Therapeutic antibodies are a rapidly expanding sector in the pharmaceutical industry.
  • The U.S. Food and Drug Administration (FDA) has approved 18 monoclonal antibodies, with over 150 in clinical development.
  • Innovation is driving the evolution of antibody-based therapeutics beyond traditional molecular structures.

Purpose of the Study:

  • To provide a concise overview of methods used to engineer antibody molecules.
  • To highlight how antibodies are being tailored for improved drug performance.
  • To discuss the adaptation of antibodies for diverse biological environments.

Main Methods:

  • Review of scientific literature on antibody engineering techniques.
  • Analysis of strategies for modifying antibody structures.
  • Examination of approaches to enhance antibody functionality as drug molecules.

Main Results:

  • Antibodies are being engineered through various innovative strategies.
  • These modifications aim to overcome limitations in different biological settings.
  • Tailored antibodies demonstrate increased efficiency as therapeutic agents.

Conclusions:

  • Antibody engineering is crucial for developing advanced pharmaceutical treatments.
  • Modified antibodies offer enhanced efficacy and broader applicability in medicine.
  • The field continues to evolve, promising novel therapeutic solutions.

Related Experiment Videos